Loading...
High PARP-1 expression predicts poor survival in acute myeloid leukemia and PARP-1 inhibitor and SAHA-bendamustine hybrid inhibitor combination treatment synergistically enhances anti-tumor effects
BACKGROUND: PARP-1 plays a critical role in DNA damage repair and contributes to progression of cancer. To explore the role of PARP-1 in acute myeloid leukemia (AML), we analyzed the expression of PARP-1 in AML and its relation to the clinical prognosis. Then, we investigated the efficacy and mechan...
Na minha lista:
| Udgivet i: | EBioMedicine |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6306376/ https://ncbi.nlm.nih.gov/pubmed/30472087 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2018.11.025 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|